Aroa Biosurgery Ltd (AU:ARX) has released an update.
Aroa Biosurgery Limited has announced the issuance of 961,255 new performance rights, as disclosed on August 23, 2024. These securities, detailed in the company’s latest Appendix 3G filing, are unquoted and not intended to be quoted on the ASX. This move may interest investors tracking unquoted equity movements within the biotech firm.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.
